Home >> Marketplace Directory >> Rheonix to expand commercialization efforts, 12/15

Rheonix to expand commercialization efforts, 12/15

image_pdfCreate PDF

 

Rheonix raised $28.6 million to further expand the company’s commercialization efforts for its molecular testing platforms, the Encompass MDx and Encompass Optimum. The investment will also enable new product development and fund existing business needs. The funds are a combination of investments from existing international and domestic investors.

Rheonix, 607-257-1242

CAP TODAY
X